Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of a Suppository Based on Phenolmicin P3 and Bosexil in Control of Irritative Symptoms in Patients Undergoing Thulium Laser Enucleation of Prostate: a Single-center, Randomized, Controlled, Open Label, Phase III Study

NCT05130918 is registered in ClinicalTrials.gov with San Carlo di Nancy Hospital as lead sponsor.

NCT NCT05130918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05130918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of a Suppository Based on Phenolmicin P3 and Bosexil in Control of Irritative Symptoms in Patients Undergoing Thulium Laser Enucleation of Prostate: a Single-center, Randomized, Controlled, Open Label, Phase III Study
Lead sponsor
San Carlo di Nancy Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2019
Completion date
April 30, 2021
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph with urinary obstruction with other lower urinary tract symptoms